G-15: Selective GPR30 Antagonist for Estrogen Signaling Research

Executive Summary. G-15 is a potent, selective antagonist for the G protein-coupled estrogen receptor (GPR30/GPER), with a Ki of ~20 nM and negligible activity on ERα and ERβ even at high concentrations (APExBIO product_spec). By blocking GPR30-mediated signaling, G-15 enables targeted studies of non-genomic estrogen actions, especially intracellular calcium mobilization and PI3K/Akt pathway modulation (Wang et al., 2021). In vivo, G-15 administration reverses estrogen-induced immune and cognitive effects, confirming its utility for mechanistic research in complex biological systems. G-15’s high DMSO solubility and stability under proper storage conditions support reliable integration into cellular, biochemical, and animal assays (APExBIO product_spec). It is widely used to clarify GPR30’s distinct roles versus classical estrogen receptors in health and disease models.

Biological Rationale

Estrogen's effects in mammals are mediated by both classical nuclear estrogen receptors (ERα, ERβ) and membrane-bound G protein-coupled estrogen receptor 30 (GPR30/GPER) (Wang et al., 2021). GPR30 is primarily localized to the endoplasmic reticulum and mediates rapid, non-genomic signaling responses to ligands such as estradiol and synthetic agonists like G-1. These pathways regulate critical cellular processes, including calcium mobilization, PI3K/Akt signaling, and immune cell proliferation. Dissecting the specific contributions of GPR30 is essential for understanding estrogen action in physiology and disease, including trauma-induced immune dysfunction and neuroprotection (Wang et al., 2021).

Mechanism of Action of G-15

G-15 [(3aR,4S,9bS)-4-(6-bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline] is a small-molecule antagonist that binds selectively to GPR30 with high affinity (Ki ≈ 20 nM) (APExBIO product_spec). It competitively inhibits GPR30-mediated signaling without significant interaction with ERα or ERβ, even at micromolar doses. Upon administration, G-15 blocks estrogen- or G-1–induced intracellular calcium release and PI3K activation, preventing downstream Akt phosphorylation. In cellular assays, it inhibits G-1–induced calcium mobilization with an IC₅₀ of ~185 nM and reverses G-1–stimulated proliferation in immune and neuronal cells (Wang et al., 2021). G-15’s action is thus highly specific for GPR30-mediated, non-genomic estrogen signaling.

Evidence & Benchmarks

• G-15 selectively binds GPR30/GPER with a Ki of ~20 nM, showing <1% activity on ERα/ERβ at >10 μM (source: APExBIO product_spec).
• G-15 inhibits G-1–induced intracellular calcium mobilization in splenic CD4+ T lymphocytes with an IC₅₀ of ~185 nM (source: Wang et al., Fig. 1).
• In vivo, G-15 abolishes estradiol-induced normalization of CD4+ T cell proliferation after hemorrhagic shock, confirming GPR30’s role in immune modulation (source: Wang et al., 2021).
• G-15 impairs estradiol- or G-1–mediated improvements in spatial learning in ovariectomized rat models, supporting its use in neurological function studies (source: APExBIO product_spec).
• G-15 is insoluble in water/ethanol but dissolves in DMSO >37 mg/mL, and stock solutions are stable at ≤-20°C for short-term use (source: APExBIO product_spec).

Compared to prior overviews that focus on mechanistic summaries, this article provides updated, evidence-backed numeric benchmarks for affinity and in vivo efficacy, clarifying the boundaries of G-15’s selectivity.

For a scenario-driven guide to experimental troubleshooting with G-15, see this laboratory-focused article; the present review emphasizes validated parameters and new findings from recent literature.

For applications in neuropathic pain and neurobiology, see this review, which is complemented here by a focus on immune and cognitive models.

Common Pitfalls or Misconceptions

• G-15 does not significantly inhibit ERα or ERβ, so it cannot be used to block classical nuclear estrogen receptor signaling (source: Wang et al., 2021).
• Its efficacy is limited to GPR30-mediated pathways and does not affect all non-genomic estrogen effects, which may involve other membrane receptors (source: Wang et al., 2021).
• G-15 must be handled in DMSO; use in aqueous buffers requires appropriate dilution protocols to avoid precipitation (workflow_recommendation).
• Long-term storage of G-15 solutions can lead to degradation; always use freshly thawed or prepared stocks for experimental accuracy (workflow_recommendation).
• Results in rodent models may not fully translate to human GPR30 biology; further validation is necessary for translational studies (workflow_recommendation).

Applications, Limits & Misconceptions

G-15 is primarily used in research settings to dissect non-genomic estrogen signaling, especially in models where classical ERs and GPR30 have distinct roles. Its high selectivity allows investigators to attribute observed cellular or organismal effects specifically to GPR30 inhibition, as shown in immune, neurological, and cancer models (Wang et al., 2021). However, G-15 is not suitable for blocking all estrogen actions, and its use requires careful attention to solvent compatibility and storage to preserve activity. Misapplication or inadequate controls can lead to misinterpretation, particularly when classical ERs are also active in a system.

Workflow Integration & Parameters

Protocol Parameters

• intracellular calcium mobilization assay | IC₅₀ ≈ 185 nM | immune cell signaling, splenic CD4+ T cells | Defines potency in calcium signaling blockade | literature (Wang et al., 2021)
• GPR30 binding affinity | Ki ≈ 20 nM | target selectivity, receptor binding studies | Enables discrimination from ERα/ERβ responses | product_spec
• stock solution | ≥10 mM in DMSO, stable at ≤-20°C | all experimental formats | Maximizes solubility and shelf-life | product_spec
• working solution prep | Warm to 37°C or use ultrasonic bath for dissolution | cellular/in vivo dosing | Prevents precipitation and ensures consistent dosing | workflow_recommendation
• in vivo cognitive assay | 10 mg/kg i.p. in rats | spatial learning studies | Validates behavioral effects of GPR30 inhibition | product_spec

For more comprehensive scenario-driven protocols with troubleshooting, see this application note.

Conclusion & Outlook

G-15 (SKU B5469, APExBIO) is a reference standard for dissecting GPR30-mediated estrogen signaling. Its nanomolar potency and selectivity enable precise mechanistic studies in immunology and neurobiology, as demonstrated in cellular, ex vivo, and in vivo models (Wang et al., 2021). Continued use of G-15 is expected to refine our understanding of non-genomic estrogen pathways and to support the development of new therapeutic strategies targeting GPR30 in disease models. However, users must adhere to validated protocols and be aware of the compound’s boundaries for experimental interpretation.